Sign In
Buy ATNM
$1.11
-0.0500 (-4.31%)
At Close: Jun 04, 2026
Actinium Pharmaceuticals (ATNM) Stock Sinks As Market Gains: What You Should Know
09:45pm, Tuesday, 04'th Aug 2020
In the latest trading session, Actinium Pharmaceuticals (ATNM) closed at $0.59, marking a -1.67% move from the previous day.
Actinium (ATNM) to Report Q2 Earnings: What's in the Cards?
03:54pm, Monday, 03'rd Aug 2020
Actinium's (ATNM) lead candidate, Iomab-B, being evaluated for acute myeloid leukemia will be in focus when the company reports second-quarter earnings.
Actinium Pharmaceuticals (ATNM) Dips More Than Broader Markets: What You Should Know
09:50pm, Tuesday, 28'th Jul 2020
In the latest trading session, Actinium Pharmaceuticals (ATNM) closed at $0.59, marking a -0.78% move from the previous day.
Is Actinium Pharmaceuticals (ATNM) Outperforming Other Medical Stocks This Year?
03:30pm, Monday, 27'th Jul 2020
Is (ATNM) Outperforming Other Medical Stocks This Year?
Implied Volatility Surging for Actinium Pharmaceuticals (ATNM) Stock Options
12:57pm, Tuesday, 21'st Jul 2020
Investors need to pay close attention to Actinium Pharmaceuticals (ATNM) stock based on the movements in the options market lately.
Actinium Pharmaceuticals, Inc. (ATNM) Shares March Higher, Can It Continue?
02:32pm, Monday, 20'th Jul 2020
As of late, it has definitely been a great time to be an investor in Actinium Pharmaceuticals, Inc. (ATNM).
Actinium Pharmaceuticals Sees Hammer Chart Pattern: Time to Buy?
11:03am, Wednesday, 15'th Jul 2020
Actinium Pharmaceuticals has been struggling lately, but the selling pressure may be coming to an end soon.
Is Actinium Pharmaceuticals (ATNM) Stock Outpacing Its Medical Peers This Year?
03:30pm, Thursday, 09'th Jul 2020
Is (ATNM) Outperforming Other Medical Stocks This Year?
The Zacks Analyst Blog Highlights: Alpine Immune Sciences, Actinium Pharmaceuticals, Pacira BioSciences and Translate Bio
01:05pm, Wednesday, 08'th Jul 2020
The Zacks Analyst Blog Highlights: Alpine Immune Sciences, Actinium Pharmaceuticals, Pacira BioSciences and Translate Bio
Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) Rating Increased to Buy at Zacks Investment Research
03:08am, Sunday, 05'th Jul 2020
Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Friday, Zacks.com reports. The firm curren
Q2 2020 Earnings Estimate for Actinium Pharmaceuticals Inc Issued By William Blair (NYSEAMERICAN:ATNM)
06:10am, Friday, 03'rd Jul 2020
Actinium Pharmaceuticals Inc (NYSEAMERICAN:ATNM) – Investment analysts at William Blair raised their Q2 2020 EPS estimates for Actinium Pharmaceuticals in a research note issued to investors on Tues
Exelixis (EXEL) Receives a Buy from William Blair - Markets
03:58pm, Thursday, 02'nd Jul 2020
In a report issued on June 30, Andy Hsieh from William Blair reiterated a Buy rating on Exelixis (EXEL –
Pfenex (PFNX) Receives a Buy from William Blair - Markets
03:58pm, Thursday, 02'nd Jul 2020
In a report issued on June 29, Andy Hsieh from William Blair reiterated a Buy rating on Pfenex (PFNX –
Analysts' Top Healthcare Picks: Bristol Myers (BMY), Viking Therapeutics (VKTX) - Markets
03:58pm, Thursday, 02'nd Jul 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Bristol Myers
William Blair Sticks to Their Buy Rating for Beyondspring (BYSI) - Markets
09:57am, Friday, 26'th Jun 2020
In a report issued on June 24, Andy Hsieh from William Blair reiterated a Buy rating on Beyondspring (BYSI –
